Ciencias de la Vida y Salud
PET, SPECT, theranostics — the fastest-growing pharmaceutical manufacturing segment demands the most complex facility integration.
The market in detail
Nuclear medicine facilities combine pharmaceutical GMP, high containment and radiological shielding within a single project scope. The conventional approach — separate contractors for the GMP environment and the radiological protection — creates integration gaps where regulatory compliance fails and schedules collapse. We design and build radiopharmacy units as integrated projects: PET and SPECT hot labs, Lu-177 and Ac-225 synthesis suites, dispensing areas and quality control laboratories with shielding sized for each specific isotope.
Negative pressure for operator protection. GMP documented in line with Regulation (EU) 2023/1182 and EMA guidelines for radiopharmaceuticals. Theranostics (Lu-177 DOTATATE, Ac-225, Ra-223) and the expansion of PET diagnostic capacity across European hospital networks are the growth driver. Enforced integrates GMP and shielding. One scope. One responsibility.
GMP environments with the full Contamination Control Strategy required by the revised Annex 1.
See more →Entornos controlados aplicables
Pharmaceutical GMP, high containment and radiological shielding within a single project scope.
See more →Entornos controlados aplicables
GMP environments with the full Contamination Control Strategy required by the revised Annex 1.
See more →Entornos controlados aplicables
Pharmaceutical GMP, high containment and radiological shielding within a single project scope.
See more →Entornos controlados aplicables
GMP environments with the full Contamination Control Strategy required by the revised Annex 1.
See more →Entornos controlados aplicables
Pharmaceutical GMP, high containment and radiological shielding within a single project scope.
See more →Entornos controlados aplicables
